MEDIFAST (MED)
(Delayed Data from NYSE)
$19.88 USD
+0.18 (0.91%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $19.88 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
A Value D Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$19.88 USD
+0.18 (0.91%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $19.88 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
A Value D Growth B Momentum A VGM
Zacks News
Can AB InBev (BUD) Break Fall Even as Beer Brands Lose Fizz?
by Zacks Equity Research
AB InBev (BUD) suffers due to industry-wide decline in beer sales as consumers shift to healthier drinks. However, the company???s robust outlook indicates that there is an upside potential.
Hershey's Pirate Brands Buyout to Bolster Snacking Business
by Zacks Equity Research
Hershey (HSY) inks a deal to buy Pirate Brands from B&G Foods. Pirate Brands will be included as part of Amplify.
Campbell Down 7% in 6 Months: High Costs Not the Only Factor
by Zacks Equity Research
Campbell (CPB) posts negative sales surprise in six of the past seven quarters. The company has also been witnessing strained margins due to cost inflation.
3 Food Stocks to Buy That Are More Appetizing Than Industry
by Zacks Equity Research
While companies in the space are facing cost barriers, there are many hidden gems which have defied the industry trends with their solid strategic endeavors.
International Unit Helps Church & Dwight Reach 52-Week High
by Zacks Equity Research
Impressive second-quarter 2018 performance and robust international business drive Church & Dwight (CHD).
Here's What You Should Know About Mondelez's Long-Term Goals
by Zacks Equity Research
Mondelez (MDLZ) provides long-term targets and guidance for 2019, and reiterates projections for 2018 considering its long-term strategy.
Zacks.com highlights: athenahealth, Medifast, Commvault Systems, Molina Healthcare and Fortinet
by Zacks Equity Research
Zacks.com highlights: athenahealth, Medifast, Commvault Systems, Molina Healthcare and Fortinet
Bet on These 5 Top Liquid Stocks for Stellar Returns
by Zacks Equity Research
Five top-ranked liquid stocks that are poised to offer marvelous returns.
Can Campbell's Plans Post Strategic Review Revive the Stock?
by Zacks Equity Research
Campbell (CPB) unveils various actions as part of its prudent portfolio review and Board-led strategy, aiming at improving performance that has been drab otherwise.
5 Reasons Why Helen of Troy Stock Must be in Your Portfolio
by Zacks Equity Research
Helen of Troy (HELE) is likely to keep its stellar show on, evident from its raised earnings outlook for fiscal 2019.
Is MEDIFAST INC (MED) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Is (MED) Outperforming Other Consumer Staples Stocks This Year?
The Zacks Analyst Blog Highlights: Turtle Beach, BioLife Solutions, IntriCon and Medifast
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Turtle Beach, BioLife Solutions, IntriCon and Medifast
Church & Dwight's International Unit Strong, Margins Soft
by Zacks Equity Research
Church & Dwight's (CHD) consumer international business has been consistently contributing to organic sales growth. However, gross margin has been declining for a while now.
Boston Beer (SAM) Surges Despite Beer Woes: Will it Persist?
by Zacks Equity Research
Boston Beer (SAM) rallies despite industry headwinds, including a soft beer category, a shift to healthier drinks and higher costs. The company's non-beer portfolio shows potential for further growth.
Trump's Approval Rating Buoy Wall Street: 4 Top Gainers
by Nitish Marwah
Trump's pro-growth agenda has worked wonders for the economy as a whole.
Dean Foods Dips to a 52-Week Low, Input Costs a Key Concern
by Zacks Equity Research
Dean Foods (DF) is fighting obstacles related to input cost inflation, tepid volumes and higher retailer investments in the private label space, weighing on its performance.
Campbell (CPB) Sees Soft Q4 Earnings, Unveils Strategic Plans
by Zacks Equity Research
Campbell's (CPB) earnings fall due to higher tax rate, lower adjusted EBIT on base business and more. The company unveils various actions to improve business as part of strategic portfolio review.
Hain Celestial (HAIN) Q4 Earnings Decline Y/Y, Stock Down
by Zacks Equity Research
Hain Celestial (HAIN) witnesses the third straight quarter of sales miss in Q4. Also, high promotional and trade investments along with freight costs hurt gross margin.
Tyson Foods Down 10% in 3 Months, Market Volatility a Worry
by Zacks Equity Research
Tyson Foods' (TSN) Chicken and Pork segment witness unstable market conditions stemming from increased tariffs.
Anatomy of Success: Medifast Inc. (MED)
by Madeleine Johnson
This Zacks Rank #1 stock skyrocketed over +130% in just six months.
Sanderson Farms (SAFM) Q3 Earnings & Sales Fall Year on Year
by Zacks Equity Research
Sanderson Farms' (SAFM) Q3 results are negatively impacted by lower average selling prices and increased costs of sales.
Hormel Foods (HRL) Stock Down 5% Despite Q3 Earnings Beat
by Zacks Equity Research
Hormel Foods' (HRL) top and bottom lines improve year over year in Q3. However, sales lag estimate and management cuts sales outlook.
Hershey Up More Than 10% in 3 Months: More Room for Growth?
by Zacks Equity Research
Hershey (HSY) is gaining from its buyout of Amplify, focus on productivity improvements and brand strength. However, escalated costs remain a threat to margins.
Clorox (CLX) Surges 24% in 3 Months: More Room to Run?
by Zacks Equity Research
Clorox's (CLX) is moving up the charts thanks to its robust earnings surprise history and progress on the 2020 Strategy.
Zacks.com highlights: Medifast, Endo International, HCA Healthcare, Five9 and FTI Consulting
by Zacks Equity Research
Zacks.com highlights: Medifast, Endo International, HCA Healthcare, Five9 and FTI Consulting